InvestorsHub Logo

Amatuer17

10/20/17 4:31 AM

#200766 RE: sox040713 #200731

“Celgene's Crohn's disease drug just failed Phase 3 so they might be looking for a replacement in B-UP”

But they maybe more cautious to avoid same mistake of overpaying for drugs with success in P2.

The P3 failure is a cautionary note to all who tout no failures for IPIX - it can come anytime specially when they move to larger trials.